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CATALYTIC CLEAVAGE OF PHOSPHATE 
ESTER BONDS BY BORON CHELATES 
This application claims the bene?t of US. Provisional 
Patent Application Ser. No. 60/445,985 ?led Feb. 7, 2003. 
This invention Was made With partial Government support 
under NSF CAREER aWard CHE 9816155. The Govem 
ment may have certain rights in this invention. 
TECHNICAL FIELD 
The present invention relates to compositions and meth 
ods for cleavage of phosphate ester and ether bonds. In 
particular, the invention relates to a chelating ligand com 
prising a Group 13 element and a halide, and to methods for 
using the ligand for dealkylation of a phosphate ester or an 
ether. 
BACKGROUND OF THE INVENTION 
It is knoWn that the breaking of a phosphate ester bond is 
an important step in the destruction of chemical Warfare 
agents such as Sarin gas and VX, in the destruction of 
pesticides such as chloropyrifos, and in other biological 
systems. Such compounds irreversibly block a serine 
hydroxy group in the cellular enZyme acetylcholinesterase 
by phosphorylation, thereby disrupting the cells’ neurologi 
cal function. Accordingly, substantial effort has been 
devoted to development of methods for decontamination of 
such nerve agents and pesticides. The cleavage of the 
PA)*C bond in such nerve agents/pesticides has been 
targeted as a method of decontamination. Many such meth 
ods use d-block metals such as cobalt, copper, and Zinc. It is 
also knoWn to destroy nerve agents by hydrolyZing them 
using basic solutions and/or bleach to oxidiZe them to less 
toxic inorganic phosphates and alkali. HoWever, these solu 
tions are caustic and should only be handled under carefully 
controlled conditions. Large excesses of bleach and/or bases 
are required for successful decontamination, and the active 
agent (chlorine) in bleach decreases With time. Further, 
bases and bleach are not selective for nerve agents, and 
readily undergo undesirable and potentially explosive side 
reactions. 
Similarly, methods are knoWn for breaking the CiO4C 
bond in ethers such as methyl tertiary butyl ether (MTBE) to 
prevent, for example, contamination of groundWater 
thereby. Prior art methods include cleavage by hydrogen 
halides, organic acids, amines/amine salts, sulfonyl halides, 
inorganic acid anhydrides, LeWis acid halides, Grignard 
reagents, and alkali metal alkyls. The modes of action of 
these reagents are varied, including elimination, substitu 
tion, and oxidative cleavage. Further, it is knoWn to cleave 
MTBE by concentrated acid. HoWever, concentrated acid 
also risks contamination of the environment, and the rate of 
hydrolysis is sloW When dilute aqueous acid is used to avoid 
contamination. Biodegradation of MTBE is sloW under 
anaerobic and aerobic conditions using conventional meth 
odology, and certain methods such as gas phase catalytic 
oxidation of MTBE require high temperatures. 
There is accordingly identi?ed a need in the art for a 
successful deactivating/destroying agent for such toxic 
nerve agents as nerve gas (Sarin gas, VX, and the like) and 
organophosphate pesticides. Such an agent should be easily 
synthesiZed from inexpensive reagents, should be soluble in 
the same solvents as the nerve gases/pesticides, Will pref 
erably be selective for the nerve agents, Will not readily 
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undergo unWanted side effects upon reaction With the nerve 
agents, and Will be substantially non-toxic. 
SUMMARY OF THE INVENTION 
In accordance With the foregoing, a neW class of chelating 
ligands have been synthesiZed Which serve as catalysts for 
the dealkylation of phosphate ester and ether bonds. Each 
ligand comprises a Group 13 element and a halide. While not 
Wishing to be bound by any theory, When combined With a 
molecule containing a phosphate ester bond or an ether 
bond, it is believed that the ligand undergoes dissociation of 
a halide Which then attacks a carbon atom of the bond being 
broken, thereby cleaving the bond. 
In one aspect of the invention a chemical compound is 
provided, comprising the general formula L{YXm}n. Y may 
be selected from the Group 13 elements consisting of boron, 
aluminum, gallium, indium, and tellurium. X may be 
selected from the halide group consisting of ?uorine, chlo 
rine, bromine, iodine, and astatine. L is typically a chelating 
ligand containing at least one binding atom contacting the 
Group 13 element, the atom selected from the group con 
sisting of C, N, O, and S, and m and n are integers having 
a value of at least 1. 
In another aspect, L may be a Schilf base-containing 
ligand. Y may be selected from the Group 13 elements 
consisting of boron, aluminum, gallium, indium, and tellu 
rium, and X may be selected from the halide group consist 
ing of ?uorine, chlorine, bromine, iodine, and astatine. In 
one embodiment, L may be a salen ligand Which is bidentate, 
quadridentate, or greater. Typically, L is selected from the 
group consisting of Salen (tBu), Salpen (tBu), Salben (tBu), 
and Salhen (tBu). The general formula of the chemical 
compound may be: 
In yet another aspect, a method is provided for dealkyla 
tion of a phosphate ester or an ether, comprising contacting 
the phosphate ester or ether With a compound comprising the 
general formula L{YXm}n as described above. As described, 
L is typically a salen ligand, Y is typically boron or alumi 
num, and X is typically chlorine, bromine, or iodine. 
In still yet another aspect of the present invention, a 
catalytic method for dealkylation of a phosphate ester or an 
ether, comprising contacting the phosphate ester or ether 
With the compositions as described above in the presence of 
BBr3. The phosphate ester or ether and BBr3 may be added 
US 7,166,591 B1 
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in equimolar amounts. Typically, the dealkylation reaction 
using the compositions and methods of the present invention 
is conducted at ambient temperature. Addition of an excess 
of BBr3 renders the reaction catalytic, allowing regeneration 
of the original composition and continuation of the reaction. 
Yet still further, the present invention provides a catalytic 
method for dealkylation of a phosphate ester or an ether, 
comprising contacting the phosphate ester or ether With a 
compound comprising the general formula L{YXm}n 
WhereinY is selected from the Group 13 elements consisting 
of boron, aluminum, gallium, indium, and tellurium, X is 
selected from the halide group consisting of ?uorine, chlo 
rine, bromine, iodine, and astatine, L is a chelating ligand 
containing at least tWo molecules E and E' contacting the 
Group 13 element, the molecules E and E' being selected 
from the group consisting of C, N, O, and S, and m and n are 
integers having a value of at least 1. Typically, the compound 
generates a cationic intermediate upon contacting the phos 
phate ester or ether, the cationic intermediate having the 
general formula: 
As describing above, L may be a Schilf base-containing 
ligand, such as a salen ligand. L may be a bidentate ligand, 
a quadridentate ligand, or greater. In one embodiment, L is 
selected from the group consisting of Salen (tBu), Salpen 
(tBu), Salben (tBu), and Salhen (tBu). The reaction is ren 
dering catalytic by conducting it in the presence of BBr3. 
The phosphate ester or ether and BBr3 may be added in 
equimolar amounts. The dealkylation reaction may be con 
ducted at ambient temperature. 
Other objects of the present invention Will become appar 
ent to those skilled in this art from the folloWing description 
Wherein there is shoWn and described a preferred embodi 
ment of this invention, simply by Way of illustration of the 
modes currently best suited to carry out the invention. As it 
Will be realiZed, the invention is capable of other different 
embodiments and its several details are capable of modi? 
cation in various, obvious aspects all Without departing from 
the invention. Accordingly, the draWings and descriptions 
Will be regarded as illustrative in nature and not as restric 
tive. 
BRIEF DESCRIPTION OF THE DRAWING 
The accompanying draWings incorporated in and forming 
a part of the speci?cation illustrates several aspects of the 
present invention and, together With the description, serves 
to explain the principles of the invention. In the draWing: 
FIG. 1 is a structural depiction of a bidentate ligand 
according to the present invention, Wherein X is a halide; 
FIG. 2 is a structural depiction of a quadridentate ligand 
according to the present invention, Wherein X is a halide and 
L is a quadridentate Schilf base ligand; 
FIG. 3 schematically depicts preparation of a bidentate 
ligand according to the present invention by combining 
Salpen(zBu)[B(OMe)2]2 (l) and Salben(tBu)[B(OMe)2]2 (2) 
With a stoichiometric amount of BBr3; 
FIG. 4 graphically shoWs a catalytic process for dealky 
lation of a phosphate ester according to the present inven 
tion; and 
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FIG. 5 schematically depicts the formation of a cationic 
intermediate from a composition of the present invention. 
Reference Will noW be made in detail to the presently 
preferred embodiments of the invention, examples of Which 
are illustrated in the accompanying draWings. 
DETAILED DESCRIPTION OF THE 
INVENTION 
In accordance With one aspect of the present invention, 
the composition provided by the present invention may be a 
chelate having the general formula L{YXm}n, Where Y is a 
Group 13 element, X is a halide, and L is chelating ligand 
having a bidentate binding site comprising sites E and E' 
contacting the Group 13 element. E and E' may be O, N, P, 
S, or any combination thereof. Both bidentate (FIG. 1), 
quadridentate (FIG. 2), and greater ligands are contemplated 
by the present invention. The compositions of the present 
invention shoW excellent activity in dealkylating various 
phosphates and ethers as Will be shoWn herein. An additional 
advantage is that the method of the present invention may be 
conducted at room temperature. 
In one embodiment, the present invention provides a 
chemical compound comprising a chelating ligand L Which 
is a salen ligand, Which may have the general formula: 
As discussed previously, Y may be selected from the Group 
13 elements consisting of boron, aluminum, gallium, 
indium, tellurium, and any combination thereof. X may be 
selected from the halide group consisting of ?uorine, chlo 
rine, bromine, iodine, astatine, and any combination thereof. 
E and E' may be selected from the group consisting of C, N, 
O, S, and any combination thereof, and n is an integer having 
a value of at least 1. 
Other aspects of the present invention Will become appar 
ent to those skilled in this art from the folloWing description 
Wherein there is shoWn and described a preferred embodi 
ment of this invention, simply by Way of illustration of one 
of the modes best suited to carry out the invention. As it Will 
be realiZed, this invention is capable of other different 
embodiments and its several details are capable of modi? 
cation in various, obvious aspects all Without departing from 
the intended scope of the invention. Accordingly, the 
descriptions and examples herein Will be regarded as illus 
trative in nature and not as restrictive. 
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EXAMPLE 1 
Preparation of Salpen("Bu)(BBr2)2 
Binuclear boron bromides Were prepared in high yields by 
combining Salpen("Bu)[B(OMe)2]2 or Salben(’Bu) 
[B(OMe)2]2 With a stoichiometric amount of BBr3. To a 
stirring solution of Salpen(tBu)[B(OMe)2]2 (3.0 g, 4.62 
mmol) in toluene (50 ml) Was added 1 M BBr3 in heptane 
(6.24 ml, 6.24 mmol). The reaction mixture Was stirred for 
24 hours, and the solvent removed. The remaining solid Was 
Washed With 10 ml of hexanes, and ?ltration and vacuum 
drying yielded 3.28 g (88% yield) Salpen(tBu)(BBr2)2. 
EXAMPLE 2 
Preparation of Salben("Bu)(BBr2)2 
To a stirring solution of Salben(tBu)[B(OMe)2]2 (1.0 g, 
1.51 mmol) in toluene (50 ml) Was added 1 M BBr3 in 
heptane (2.04 ml, 2.04 mmol). The reaction mixture Was 
stirred for 18 hours at room temperature. The solution Was 
concentrated to 10 ml, ?ltered, and dried. The yield Was 0.96 
g (76% yield) Salben(’Bu)(BBr2)2. 
NMR analysis shoWed a broad single peak (at 6 —0.57 and 
—0.40 ppm, respectively) for both binuclear boron bromide 
compounds prepared as described in Examples 1 and 2, 
up?eld from a related chloride analogue Salpen("Bu)[BCl2]2 
(at 6 6.21 ppm). 
EXAMPLE 3 
Dealkylation of Phosphates With Salpen(’Bu) 
(BBr2)2 
Salpen(tBu)(BBr2)2, prepared as described in Example 1, 
Was evaluated for its ability to dealkylate various phosphate 
esters. In a NMR tube, phosphate Was added to an equimolar 
solution of Salpen(tBu)(BBr2)2 in CDCl3 and held at room 
temperature for 30 minutes. The reaction Was monitored by 
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1H NMR. As shoWn in Table 1, signi?cant dealkylation, 
measured by the amount of phosphate remaining in the 
reaction mixture in comparison to the amount of alkyl 
bromide produced, could be achieved With the composition 
of the present invention. 
TABLE 1 
Percent dealkylation of phosphates With Sa1pen(‘Bu)(BBr7)7 
“The percent conversion Was determined by the amount of phosphate 
remaining to the amount of alkyl bromide produced in the 1H NMR. 
EXAMPLE 4 
Dealkylation of Phosphates With Binuclear Boron 
Compounds 
Various binuclear boron compounds, synthesiZed substan 
tially as described in Examples 1 and 2, Were evaluated for 
dealkylation of phosphate esters as described in Example 3. 
For comparison, a positive control consisting of BBr3 in 
CDCl3 Was used. As shoWn in Tables 245, the compounds of 
the present invention Were e?cective in cleaving phosphate 
bonds for various phosphate compounds. In contrast, BBr3 
Was ine?cective (Table 5). Activity of the boron halide 
compounds of the present invention did not decrease With 
extension of the alkyl chain on the phosphates. HoWever, a 
slight decrease in activity of the compounds Was observed 
With the branched phosphates such as (PhO)2((2-Et)HexO) 
P(O). 
TABLE 2 
Dealkylation of phosphates by Salen ligands having the formula L[BBr2]2. 
Phosphate 
(PhO)2P(O) 
30 24 30 24 30 24 30 24 30 24 30 24 
L[BBr2]2 min. hr. min. hr. min. hr. min. hr. min. hr. min. hr. 
Sa1en(t) 76 94 26 32 42 57 61 77 48 58 88 89 
Salpen(t) 74 82 68 74 99 99 84 99 75 83 98 98 
Salben(t) 60 78 46 53 77 91 87 92 64 81 90 96 
Salhen(t) 58 81 55 66 60 69 37 47 88 93 79 79 
US 7,166,591 B1 
TABLE 3 
Dealkylation of phosphates by Salen ligands having the formula L[MePhBBr7]7. 
Phosphate 
(PhO)2P(O) 
(MeO)1P(O) (EtO)1P(O) (n—BuO)1P(O) (MeO)7P(O)H (MeO)7P(O)Me (i—PrO)7P(O)H (2-ethvlhexvl) (MeSiO)1P(O) 
30 24 30 24 30 24 30 24 30 24 30 24 30 24 30 24 
L[MePhBBr]2 min hr. min hr. min hr. min hr. min hr. min hr. min hr. min. hr. 
Salen(t) 45 62 40 98 31 46 59 67 47 56 42 74 12 32 43 45 
Salpen(t) 52 69 50 64 58 75 67 82 64 69 32 65 46 67 48 63 
Salben(t) 92 83 71 98 70 99 50 82 50 63 37 74 52 76 69 69 
Salhen(t) 80 88 56 98 47 98 50 76 42 66 26 60 42 61 89 89 
bond of a phosphate ester or ether, respectively, allowing a 
TABLE 4 nucleophilic attack by the halide at the ot-carbon. The 
I I I reaction is depicted schematically in FIG. 5, using a phos 
Dmlkylanon of Phosphms by Sal“ hgands havmg the 20 phate ester and a binuclear boron compound according to the 
formula L[BCl7]7. . . . present 1nvent1on as an example. Accordingly, the present 
phosbhate invention contemplates use of such cationic intermediates 
for dealkylation of phosphate esters and ethers as described 
(MeO)1P(O) (MeSiO)1P(O) herein 
25 
L[BCl2]2 30 min. 24 hr. 30 min. 24 hr. EXAMPLE 6 
Salen(t) 7 45 84 87 
Salpen(t) 20 32 66 75 Cleavage Of MTBE 
Salben(t) 11 53 81 84 
Salhen(t) 7 47 57 63 _ _ 
gamma) 4; 62 73 86 30 Methyl tertlary butyl ether Was added to a CDCl3 solut1on 
of binuclear boron ligands synthesized substantially as 
described in Examples 1 and 2 (4:1 ratio of MTBEzligand). 
TABLE 5 
Dealglation of phosphates by BBr3. 
Phosphate 
(PhO)2P(O) 
(MeO)1P(O) (EtO)1P(O) (n—BuO)1P(O) (MeO)7P(O)H (MeO)7P(O)Me (i—PrO)7P(O)H (2-ethvlhexvl) (MeSiO)1P(O) 
30 24 30 24 30 24 30 24 30 24 30 24 30 24 30 24 
min. hr. min. hr. min. hr. min hr. min hr. min hr. min hr. min. hr. 
BBr3 1.1 3.4 0 2.7 5 0 1 12 2 2 0 0 0 7 11 20 
B-Bromo 74 99 37 66 31 54 84 87 58 92 76 84 87 95 99 99 
aB-Bromocatecholborane 
EXAMPLE 5 The solution Was held at room temperature, and the reaction 
Catalytic Process for Dealkylating Phosphates 
Because Salpen("Bu)(BBr2)2 can be generated in situ from 
Salpen("Bu)[B(OMe)2]2 and BBr3, the process can be made 
catalytic. The reaction is shoWn schematically in FIG. 4. In 
a NMR tube, equimolar amounts of (MeO)3P(O) and BBr3 
Were added to a solution of Salpen(’Bu)(BBr2)2 in CDCl3 in 
the ratio of 20:1 of phosphate to borate and held at room 
temperature. The reaction Was monitored by 1H NMR. 
Dealkylation of trimethyl phosphate occurred Within ?ve 
minutes. Dealkylation (75% conversion) occurred Within 30 
minutes at a substrate to catalyst ratio of 200:1. 
While not Wishing to be bound by any theory, the mecha 
nism may be one in Which a cationic intermediate, Which 
may be depicted in one embodiment of this invention as 
[(chelate)BBr]+, coordinates the PiO4C or C4O4C 
50 
55 
60 
65 
monitored by 1H NMR. Percent dealkylation Was monitored 
by comparing the amount of methyl bromide produced to the 
amount of trimethyl phosphate remaining. As shoWn in 
Table 6, the compositions of the present invention are 
capable of dealkylating ethers as Well as phosphate esters. 
TABLE 6 
Cleavage of MTBE by bimetallic boron halide ligand. 
Conversion (%)"‘ 
Ligand 30 min. 24 hr. 
Salen(‘Bu)[BBr2]2 12 39.3 
Salpen(‘Bu)[BBr2]2 3 10 
US 7,166,591 B1 
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TABLE 6-continued 
Cleavage of MTBE by bimetallic boron halide ligand. 
Conversion % “ 
Ligand 30 min. 24 hr. 
Salben(‘Bu)[BBr2]2 5 25 
SalhenCBu)[BBr2]2 1 8 
3Percent dealkylation Was determined by comparing the amount of methyl 
bromide produced to the amount of trimethyl phosphate remaining in the 
1H NMR. 
The foregoing description is presented for purposes of 
illustration and description of the various aspects of the 
invention. The descriptions are not intended to be exhaustive 
or to limit the invention to the precise form disclosed. The 
embodiments described above Were chosen to provide the 
best illustration of the principles of the invention and its 
practical application to thereby enable one of ordinary skill 
in the art to utilize the invention in various embodiments and 
With various modi?cations as are suited to the particular use 
contemplated. All such modi?cations and variations are 
Within the scope of the invention as determined by the 
appended claims When interpreted in accordance With the 
breadth to Which they are fairly, legally and equitably 
entitled. 
What is claimed is: 
1. A chemical compound having a chelating ligand L of 
the general formula: 
tBu 
Wherein Y is selected from the Group 13 elements con 
sisting of boron, aluminum, gallium, indium, and tel 
lurium, X is selected from the halide group consisting 
of ?uorine, chlorine, bromine, iodine, and astatine, E 
and E' are selected from the group consisting of C, N, 
O, and S, and n is an integer having a value of at least 
1. 
2. The chemical compound of claim 1, Wherein L is 
selected from the group consisting of Salen (tBu), Salpen 
(tBu), Salben (tBu), and Salhen (tBu). 
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3. The chemical compound of claim 1, Wherein Y is boron 
or aluminum. 
4. The chemical compound of claim 1, Wherein X is 
chlorine, bromine, or iodine. 
5. The chemical compound of claim 1, Wherein n is 2. 
6. A composition comprising a chelating ligand L, the 
ligand having the general formula: 
Wherein Y is selected from the Group 13 elements con 
sisting of boron, aluminum, gallium, indium, and tel 
lurium, X is selected from the halide group consisting 
of ?uorine, chlorine, bromine, iodine, and astatine, E 
and E' are selected from the group consisting of C, N, 
O, and S, and n is an integer having a value of at least 
1. 
7. A method for dealkylation of a phosphate ester or an 
ether, comprising contacting the phosphate ester or ether 
With the chemical compound of claim 1. 
8. The method of claim 7, wherein: 
L is selected from the group consisting of Salen (tBu), 
Salpen (tBu), Salben (tBu), and Salhen (tBu); 
Y is boron or aluminum; 
X is chlorine, bromine, or iodine; and 
n is 2. 
9. A catalytic method for dealkylation of a phosphate ester 
or an ether, comprising contacting the phosphate ester or 
ether With the chemical compound of claim 1 in the presence 
of BBr3. 
10. The method of claim 9, Wherein: 
L is selected from the group consisting of Salen (tBu), 
Salpen (tBu), Salben (tBu), and Salhen (tBu); 
Y is boron or aluminum; 
X is chlorine, bromine, or iodine; and 
n is 2. 
11. The method of claim 9, Wherein the phosphate ester or 
ether and BBr3 are present in equimolar amounts. 
12. The method of claim 9, Wherein the dealkylation is 
conducted at ambient temperature. 
* * * * * 
